(266 days)
Not Found
No
The summary describes standard CBCT technology and image reconstruction algorithms, with no mention of AI or ML.
No
The device is described as an imaging system for diagnostic purposes, not for treating or rehabilitating a medical condition.
No
Explanation: The device is an imaging system (CT scanner) intended for acquiring images of anatomical structures. While these images are used by healthcare professionals for diagnosis, the device itself produces images, not a diagnosis. Therefore, it is a medical imaging device facilitating diagnosis rather than a diagnostic device that performs the diagnosis itself.
No
The device description clearly outlines hardware components including an X-ray unit, flat panel detector, motorized gantry, and the system is described as a compact, stand-alone unit.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "X-ray computed tomography imaging of anatomies within upper and lower extremities." This describes an imaging device used to visualize internal structures of the body.
- Device Description: The description details a CBCT (Cone Beam Computed Tomography) system that acquires X-ray images and reconstructs them into volumetric images. This is consistent with medical imaging equipment.
- Lack of IVD Characteristics: An IVD device is used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device does not interact with or analyze such specimens.
The device is clearly a medical imaging device used for diagnostic purposes, but it falls under the category of medical imaging equipment, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
Planmed Verity is intended to be used for X-ray computed tomography imaging of anatomies within upper and lower extremities.
The device is to be operated and used by legally qualified health care professionals.
Product codes (comma separated list FDA assigned to the subject device)
JAK
Device Description
Planmed Verity utilizes the CBCT (Cone Beam Computed Tomography) technology with a flat panel detector to provide high resolution volumetric images. During image acquisition the detector and X-ray tube perform a single rotation around the target of imaging, during which an amount of snapshot X-ray images are acquired. The X-ray radiation is pulsed so that it is active only when data is collected for the projection images. Before reconstruction, calibration corrections are applied to the image data. The reconstruction is then performed using a dedicated reconstruction engine and algorithm.
The system is designed as a compact, stand-alone unit from which the whole imaging procedure from patient information management to image acquisition, processing and archiving can be performed.
The unit provides a motorized gantry with adjustable height and tilt for the best possible extremity positioning. The construction also enables a weight-bearing option, in which the patient stands inside the gantry during image acquisition. Weight-bearing imaging of the extremity shows the anatomy under natural load.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray computed tomography (Cone Beam Computed Tomography)
Anatomical Site
upper and lower extremities
Indicated Patient Age Range
Not Found
Intended User / Care Setting
legally qualified health care professionals.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Comparative non-clinical studies were completed to compare the imaging performance of Planmed Verity and the predicate device. The non-clinical comparison included common image quality measures such as high contrast resolution, image noise and Hounsfield Unit (HU) accuracy measured from test objects of relevant size and composition in respect to the anatomies to be imaged with Planmed Verity. A clinical study was also completed to evaluate the image quality of Planmed Verity. The images for this clinical study were selected from patients imaged as part of normal clinical routine in a university hospital in Finland (where appropriate regulatory approvals for the unit are already in effect). Based on the non-clinical studies the imaging performance of Planmed Verity was found both substantially equivalent to the predicate device and sufficient for clinical use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
K 21418 Planmed
ENCLOSURE 7 P. 7-1
510(K) SUMMARY
FEB 1 2013
DATE January 10th, 2012
PRODUCT, CLASSIFICATION NAME
Trade name: Planmed Verity Common name: Computed Tomography X-ray System Classification: JAK, Class II Regulation number: 21 CFR 892.1750 -
MANUFACTURER
Planmed Oy Sorvaajankatu 7 FI-00880 Helsinki, Finland Phone: +358 20 7795 300 Fax: +358 20 7795 396 Contact person: Lars Moring
UNITED STATES SALES REPRESENTATIVE (U.S. DESIGNATED AGENT)
Planmed USA Inc. 100 North Gary Avenue, Suite A Roselle, IL 60172 Phone: (630) 894 2200 Fax: (630) 894 4271 Contact person : Bob Pienkowski
INTENDED USE
Planmed Verity is intended to be used for X-ray computed tomography imaging of anatomies within upper and lower extremities.
The use of Planmed Verity X-ray unit is allowed only under supervision of a health care professional.
PRODUCT DESCRIPTION
Planmed Verity utilizes the CBCT (Cone Beam Computed Tomography) technology with a flat panel detector to provide high resolution volumetric images. During image acquisition the detector and X-ray tube perform a single rotation around the target of imaging, during which an amount of snapshot X-ray images are acquired. The X-ray radiation is pulsed so that it is active only when data is collected for the projection images. Before reconstruction, calibration corrections are applied to the image data. The reconstruction is then performed using a dedicated reconstruction engine and algorithm.
The system is designed as a compact, stand-alone unit from which the whole imaging procedure from patient information management to image acquisition, processing and archiving can be performed.
1
ENCLOSURE 7 P. 7-2
The unit provides a motorized gantry with adjustable height and tilt for the best possible extremity positioning. The construction also enables a weight-bearing option, in which the patient stands inside the gantry during image acquisition. Weight-bearing imaging of the extremity shows the anatomy under natural load.
PREDICATE DEVICE
We consider this product to be similar in design, composition to the following device introduced into commercial distribution after May 28, 1976:
510(k) # K061834 Xoran xCATTM
SUBSTANTIAL EQUIVALENCE
The intended use of Planmed Verity and the predicate device is similar. Planmed Verity is intended to be used for imaging anatomies within upper and lower extremities. Intended use of the predicate device covers these same areas and, additionally, other anatomies such as head and neck. Planmed Verity and the predicate device both utilize cone beam computed tomography technology with substantially equivalent technical characteristics for acquiring 3D image data sets of these anatomical areas.
Comparative non-clinical studies were completed to compare the imaging performance of Planmed Verity and the predicate device. The non-clinical comparison included common image quality measures such as high contrast resolution, image noise and Hounsfield Unit (HU) accuracy measured from test objects of relevant size and composition in respect to the anatomies to be imaged with Planmed Verity. A clinical study was also completed to evaluate the image quality of Planmed Verity. The images for this clinical study were selected from patients imaged as part of normal clinical routine in a university hospital in Finland (where appropriate regulatory approvals for the unit are already in effect). Based on the non-clinical studies the imaging performance of Planmed Verity was found both substantially equivalent to the predicate device and sufficient for clinical use.
CONCLUSION
The comparison of characteristics between Planmed Verity and the predicate device demonstrate that Planmed Verity is as safe and effective as the predicate device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged in a circular fashion around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 1, 2013
Mr. Lars Moring Regulatory Affairs Manager Planmed Oy Sorvaajankatu 7, FI-00880 HELSINKI FINLAND
Re: K121418
Trade/Device Name: Planmed Verity Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: December 21, 2012 Received: December 26, 2012
Dear Mr. Moring:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
3
Page 2-Mr. Moring
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Sean M. Boyd -S for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K121418
Device Name:
Planmed Verity
Indications For Use:
Planmed Verity is intended to be used for X-ray computed tomography imaging of anatomies within upper and lower extremities.
The device is to be operated and used by legally qualified health care professionals.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Sean M. Boyd -S 2013.02.01 14:52:17 -05'00'
(Division Sign-Off) Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health
510(k) K121418
Page 1 of 1